New single-dose pill may beat week-long treatment for common STI
NCT ID NCT06261840
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two oral treatments for trichomonas, a common sexually transmitted infection. About 1,200 women and men with a positive test will receive either a single dose of secnidazole or multiple doses of metronidazole over several days. The goal is to see which approach cures more people at one month and is more cost-effective.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL VAGINITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
LSU-CrescentCare Sexual Health Center
RECRUITINGNew Orleans, Louisiana, 70119, United States
-
Segal Trials Healthcare Clinical Data, Inc. 1065 NE 125th St. Suite 417 North Miami, FL 33161
NOT_YET_RECRUITINGNorth Miami, Florida, 33161, United States
-
UAB Sexual Health Research Clinic [SHRC]
RECRUITINGBirmingham, Alabama, 35205, United States
-
University of Alabama at Birmingham [UAB] Gynecology Clinics
RECRUITINGBirmingham, Alabama, 25233, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.